KNSA vs MTD · P/E 53, rev $677.6M vs P/E 27, rev $1.97B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the KNSA and MTD stock pages for the full models.
Not investment advice.